The US Bankruptcy Court granted an order for the extension of the exclusivity periods for Sorrento Therapeutics, Inc. on December 18, 2023. As per the order, the debtor?s exclusivity period to file its plan and to solicit votes on its plan, have been extended by 42 days i.e. up to January 8, 2024 and March 8, 2024, respectively.